chr12-221512-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_016615.5(SLC6A13):c.1550C>T(p.Pro517Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,610,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016615.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A13 | NM_016615.5 | c.1550C>T | p.Pro517Leu | missense_variant | 14/15 | ENST00000343164.9 | NP_057699.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A13 | ENST00000343164.9 | c.1550C>T | p.Pro517Leu | missense_variant | 14/15 | 1 | NM_016615.5 | ENSP00000339260.4 | ||
SLC6A13 | ENST00000445055.6 | c.1274C>T | p.Pro425Leu | missense_variant | 12/13 | 2 | ENSP00000407104.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000807 AC: 2AN: 247834Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133952
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1458608Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 725498
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.1550C>T (p.P517L) alteration is located in exon 14 (coding exon 13) of the SLC6A13 gene. This alteration results from a C to T substitution at nucleotide position 1550, causing the proline (P) at amino acid position 517 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at